| Title | American Journal of Cardiovascular Drugs |
| Abbreviation | Am. J. Cardiovasc. Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2) |
| h-index | 57 |
| Overall Rank/Ranking | 5546 |
| SCImago Journal Rank (SJR) | 0.841 |
| Impact Score | 3.12 |
| Publisher | Adis International Ltd |
| Country | United Kingdom |
| ISSN | 11753277, 1179187X |
| Best Quartile | Q2 |
| Coverage History | 2001-2022 |
American Journal of Cardiovascular Drugs is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published by Adis International Ltd. The overall rank of American Journal of Cardiovascular Drugs is 5546. According to SCImago Journal Rank (SJR), this journal is ranked 0.841. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 57. The best quartile for this journal is Q2.
The ISSN of American Journal of Cardiovascular Drugs journal is 11753277, 1179187X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. American Journal of Cardiovascular Drugs is cited by a total of 524 articles during the last 3 years (Preceding 2022).
The impact score (IS) 2022 of American Journal of Cardiovascular Drugs is 3.12, which is computed in 2023 as per its definition. American Journal of Cardiovascular Drugs IS is decreased by a factor of 0.44 and approximate percentage change is -12.36% when compared to preceding year 2021, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2022 of American Journal of Cardiovascular Drugs is 3.12. If the same downward trend persists, impact score may fall in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.12 |
| 2021 | 3.56 |
| 2020 | 2.86 |
| 2019 | 2.60 |
| 2018 | 2.40 |
| 2017 | 2.85 |
| 2016 | 2.98 |
| 2015 | 2.49 |
| 2014 | 2.60 |
American Journal of Cardiovascular Drugs has an h-index of 57. It means 57 articles of this journal have more than 57 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of American Journal of Cardiovascular Drugs is 11753277, 1179187X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of American Journal of Cardiovascular Drugs is 5546. According to SCImago Journal Rank (SJR), this journal is ranked 0.841. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.841 |
| 2021 | 1.010 |
| 2020 | 1.063 |
| 2019 | 0.854 |
| 2018 | 0.903 |
| 2017 | 0.951 |
| 2016 | 0.927 |
| 2015 | 0.920 |
| 2014 | 0.992 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5546 |
| 2021 | 4040 |
| 2020 | 3987 |
| 2019 | 5437 |
| 2018 | 5003 |
| 2017 | 4667 |
| 2016 | 4876 |
| 2015 | 4962 |
| 2014 | 4385 |
American Journal of Cardiovascular Drugs is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of American Journal of Cardiovascular Drugs is Am. J. Cardiovasc. Drugs. This abbreviation ('Am. J. Cardiovasc. Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the American Journal of Cardiovascular Drugs is 3.12. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 3.56 (2021) and 2.40 (2018), respectively, in the last 9 years. Moreover, its average IS is 2.83 in the previous 9 years.
The American Journal of Cardiovascular Drugs has an SJR (SCImago Journal Rank) of 0.841, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.063 in 2020 and the lowest being 0.841 in 2022. Furthermore, the average SJR of the American Journal of Cardiovascular Drugs over the previous 9-year period stands at 2.83.
The latest h-index of the American Journal of Cardiovascular Drugs is 57.
The American Journal of Cardiovascular Drugs is published by the Adis International Ltd, with its country of publication being the United Kingdom.
The American Journal of Cardiovascular Drugs is currently ranked 5546 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3987 in 2020 and its lowest position of 5546 in 2022.
The standard ISO4 abbreviation for the American Journal of Cardiovascular Drugs is Am. J. Cardiovasc. Drugs.
American Journal of Cardiovascular Drugs is classified as a journal that the Adis International Ltd publishes.
The American Journal of Cardiovascular Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The American Journal of Cardiovascular Drugs is assigned the following International Standard Serial Numbers (ISSN): 11753277, 1179187X.
The best quartile for the American Journal of Cardiovascular Drugs is Q2 (2022).
The American Journal of Cardiovascular Drugs coverage history can be summarized as follows: 2001-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Applied Ecology and Environmental Research | journal | 17545 | Corvinus University of Budapest | 38 | 0.74 |
| Milan Journal of Mathematics | journal | 3120 | Birkhauser Verlag Basel | 28 | 1.79 |
| Materials Research | journal | 14791 | Universidade Federal de Sao Carlos | 65 | 1.62 |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| Child and Family Social Work | journal | 8628 | Wiley-Blackwell Publishing Ltd | 67 | 2.20 |
| World Englishes | journal | 4960 | Wiley-Blackwell | 60 | 1.97 |
| Educational Measurement: Issues and Practice | journal | 4494 | Wiley-Blackwell Publishing Ltd | 59 | 1.53 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Population Review | journal | 17841 | Sociological Demography Press | 13 | 0.73 |
| Built Environment | journal | 12797 | Alexandrine Press | 43 | 1.15 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.12 |
| 2021 | 3.56 |
| 2020 | 2.86 |
| 2019 | 2.60 |
| 2018 | 2.40 |
| 2017 | 2.85 |
| 2016 | 2.98 |
| 2015 | 2.49 |
| 2014 | 2.60 |
3.12
57
5546
0.841
